This book deals with the application of pharmacogenomics in dermatological treatments. It explores how genetic factors influence responses to therapies for conditions like psoriasis, eczema, and melanoma. The text emphasizes personalized approaches to enhance treatment efficacy and minimize adverse effects in dermatology. Ideal for dermatologists and pharmacogenomic specialists, it promotes precision medicine in skin care and treatment.
Ashley Chapman integrates pharmacogenomics into precision dermatology to tailor treatments based on individual genetic profiles, enhancing efficacy and reducing side effects. Her research focuses on how genetic variations impact responses to therapies for conditions like acne, psoriasis, and rosacea. Ashley has authored numerous studies on the application of pharmacogenomic data to develop personalized treatment plans for improved skin health outcomes. She also offers guidelines for clinicians to adopt precision pharmacogenomic strategies in their dermatological practice, promoting individualized and effective patient care through genetic-informed approaches.